Inventiva Ownership
| IVA Stock | USD 2.59 0.01 0.38% |
Shares in Circulation | First Issued 2012-12-31 | Previous Quarter 52 M | Current Value 52 M | Avarage Shares Outstanding 23.7 M | Quarterly Volatility 14.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Inventiva |
Inventiva Stock Ownership Analysis
The company recorded a loss per share of 2.14. Inventiva Sa had not issued any dividends in recent years. Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on NASDAQ Exchange in the United States. To learn more about Inventiva Sa call Frederic Cren at 33 3 80 44 75 00 or check out https://www.inventivapharma.com.Besides selling stocks to institutional investors, Inventiva also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Inventiva's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Inventiva's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Inventiva Quarterly Liabilities And Stockholders Equity |
|
Inventiva Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Inventiva is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inventiva Sa backward and forwards among themselves. Inventiva's institutional investor refers to the entity that pools money to purchase Inventiva's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Yiheng Capital Llc | 2024-09-30 | 2.6 M | Nea Management Company, Llc | 2024-09-30 | 1.5 M | Bvf Inc | 2024-09-30 | 686 K | Commonwealth Equity Services Inc | 2024-09-30 | 39.7 K | Susquehanna International Group, Llp | 2024-09-30 | 16.3 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.4 K | Covestor Ltd | 2024-09-30 | 337 | Virtu Financial Llc | 2024-06-30 | 0.0 | Ubs Group Ag | 2024-09-30 | 0.0 |
Inventiva Outstanding Bonds
Inventiva issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Inventiva Sa uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Inventiva bonds can be classified according to their maturity, which is the date when Inventiva Sa has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Inventiva Corporate Filings
6K | 26th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 13th of November 2024 Other Reports | ViewVerify | |
F3 | 21st of October 2024 An amendment to the original Schedule 13D filing | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Inventiva Sa offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inventiva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inventiva Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inventiva Sa Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inventiva Sa. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inventiva. If investors know Inventiva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inventiva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.14) | Revenue Per Share 0.383 | Quarterly Revenue Growth (0.59) | Return On Assets (1.13) | Return On Equity (16.43) |
The market value of Inventiva Sa is measured differently than its book value, which is the value of Inventiva that is recorded on the company's balance sheet. Investors also form their own opinion of Inventiva's value that differs from its market value or its book value, called intrinsic value, which is Inventiva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inventiva's market value can be influenced by many factors that don't directly affect Inventiva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inventiva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inventiva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inventiva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.